Great news about Cogane!
This seems to be a treatment we can really get excited about -- unique in a number of ways. First of all -- it can be administered as a pill. It is plant-based. It induces production of GDNF, which we know is a potent neurotrophic factor. It is also being studied as a treatment for Alzheimer's, which would increase its market value. The research is being funded by both the Michael J Fox Foundation and Tom Isaac's Cure Parkinson's Trust. I think we can trust that the development of Cogane will move along with a sense of urgency, shared by all PWP. A Phytopharm press release, gives a nice summary of the development of Cogane and the early trial results --see http://www.phytopharm.com/assets/REL-155.pdf

Let's hope the phase II trial is a great success and as Chris said above "lets hope this company gets enough financial support to get through the human trials."

Amen...